Mechanisms of interactions of anti-arrhythmia agents during their combined use
Adnan Abdalla; Mazur, N.A.; Shestakova, N.V.
Kardiologiia 31(2): 87-91
1991
ISSN/ISBN: 0022-9040 PMID: 2041300 Document Number: 386685
Document emailed within 1 workday
Related Documents
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15Kotliarov, A.A.; Smirnov, L.D.; Smirnova, L.E.; Kurkina, N.V.; Balykova, L.A.; Kariakina, T.N. 2002: Combined administration of mexidol and anti-arrhythmia agents Eksperimental'naia i Klinicheskaia Farmakologiia 65(5): 31-34
Mazurowa, A.; Szadowska, A.; Szmigielski, A. 1972: Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs Kardiologia Polska 15(2): 167-175
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Du, Z.H.; Liu, H.G.; Zeng, F.D.; Hu, C.J. 1988: Effects of dauricine combined with other anti-arrhythmia agents on electrically induced ventricular fibrillation in rabbits Zhongguo Yao Li Xue Bao 9(1): 33-36
Storozhuk, B.G. 1985: Anti-arrhythmia activity and side effects of various anti-arrhythmia agents Vrachebnoe Delo 3: 41-44
Kaverina, N.V.; Lyskovtsev, V.V.; Popova, E.P. 2003: Comparative study of electrophysiological mechanisms of anti-arrhythmia IIi class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation Eksperimental'naia i Klinicheskaia Farmakologiia 66(1): 27-33
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123
Bonhorst, D. 1992: Choice of anti-arrhythmia agents: the arrhythmia-patient binomial Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 387-389
Hohnloser, S.H.; Meinertz, T.; Mehender, M.; Geibel, A.; Just, H. 1988: Induction and increase of cardiac arrhythmia by anti-arrhythmia agents Der Internist 29(5): 338-344
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Bracchi, G.; Vezzoli, F. 1976: Anti-arrhythmia agents La Clinica Terapeutica 78(1): 65-85
Kaufmann, G. 1974: Anti-arrhythmia agents Medizinische Klinik 69(18): 778-786
Haverkamp, W.; Wichter, T.; Chen, X.; Hördt, M.; Willems, S.; Rotman, B.; Hindricks, G.; Kottkamp, H.; Borggrefe, M.; Breithardt, G. 1994: The pro-arrhythmic effects of anti-arrhythmia agents Zeitschrift für Kardiologie 83(Suppl 5): 75-85
Rahn, K.H. 1975: Clinical pharmacology of anti-arrhythmia agents Medizinische Klinik 70(23): 994
Zeng, G.Y. 1983: Clinical pharmacology of anti-arrhythmia agents Zhonghua Xin Xue Guan Bing Za Zhi 11(1): 15-19
Azanza Perea, J.R.; Honorato Pérez, J.M.; Cuena Boy, R. 1984: Clinical pharmacology of anti-arrhythmia agents Revista de Medicina de la Universidad de Navarra 28(1): 37-43
Balashov, V.P.; Sosunov, E.A.; Balykova, L.A.; Sernov, L.N. 1999: Study of various mechanisms of anti-arrhythmia activity of phosphoenol pyruvate Biulleten' Eksperimental'noi Biologii i Meditsiny 128(10): 414-416
Honerjäger, P. 1990: New aspects of the molecular effect of anti-arrhythmia agents Herz 15(2): 70-78